Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Lunsumio

Hematology

Hematology Today—March 30, 2026

This week’s Hematology update highlights regulatory progress, evolving…

Hematology

Hematology Video Recap—January 12, 2026

This hematology video covers major regulatory and guideline milestones across…

Hematology

Hematology Weekly News - September 22nd 2025

Hematology Update: Inobrodib Trial, Tecvayli Combo, Bexobrutideg Data and……

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Endocrinology Today—March 31, 2026
Obesity Today—March 31, 2026
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Hematology Today—March 30, 2026
Oncology Today—March 30, 2026

Tags

10x Genomics 35Pharma Alembic Therapeutics Artificial intelligence diagnostics in diabetes Autoimmune Hemolytic Anemia Behcet’s disease Bivamelagon Bocunebart bone mineral density Cardiac Rehab Cardiovascular Risk CHA Bio Group Children’s Hospital of Philadelphia chronic disease prevention Competitive Intelligence Process Cutaneous lupus erythematosus DTX401 Duchenne MD ESC2025 Etonogestrel implant Exosome Vaccines FRRS1L Gene Therapy GLP1 drugs healthcare tech IgG4 Related Disease KRAS LDL cholesterol Macular degeneration Mankind Pharma Mantle Cell Lymphoma med tech Metformin microcystic lymphatic malformations Microplastics Nutrition Science Pediatric episodic migraine pediatric rare disease platform diligence Rezurock robotic surgery RRMS siRNA delivery Sjögrens Disease Tafasitamab transcatheter valve replacement

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Endocrinology Today—March 31, 2026
Obesity Today—March 31, 2026
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Hematology Today—March 30, 2026
Oncology Today—March 30, 2026

TAGS

10x Genomics 35Pharma Alembic Therapeutics Artificial intelligence diagnostics in diabetes Autoimmune Hemolytic Anemia Behcet’s disease Bivamelagon Bocunebart bone mineral density Cardiac Rehab Cardiovascular Risk CHA Bio Group Children’s Hospital of Philadelphia chronic disease prevention Competitive Intelligence Process Cutaneous lupus erythematosus DTX401 Duchenne MD ESC2025 Etonogestrel implant Exosome Vaccines FRRS1L Gene Therapy GLP1 drugs healthcare tech IgG4 Related Disease KRAS LDL cholesterol Macular degeneration Mankind Pharma Mantle Cell Lymphoma med tech Metformin microcystic lymphatic malformations Microplastics Nutrition Science Pediatric episodic migraine pediatric rare disease platform diligence Rezurock robotic surgery RRMS siRNA delivery Sjögrens Disease Tafasitamab transcatheter valve replacement

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy